Evidence map›Paper›PMID 40457390›Full record

ArticleItalian journal of pediatrics2025

Advanced biomarkers for prognostic evaluation of pneumonia severity in pediatric intensive care: focus on novel inflammatory and hematological ratios.

Murat Ari, Hatice Feray Ari, Hakan Cengiz

Abstract read
In one paragraph

Article in Italian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Admission SpOTranslational pediatrics · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Murat AriSöke Health Services Vocational School, Aydin Adnan Menderes University, Aydin, Turkey. muratari60@gmail.com.ORCID http://orcid.org/0000-0002-1504-7050
Hatice Feray AriDepartment of Pediatric Intensive Care, Aydin Adnan Menderes University Faculty of Medicine, Aydin, Turkey.ORCID http://orcid.org/0000-0002-2208-2524
Hakan CengizDEVA Holding A.S. Biotechnology R&D Center, Tekirdag, Turkey.ORCID http://orcid.org/0000-0002-0868-0499

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backroundIn children, community-acquired pneumonia (CAP) has a high mortality and morbidity rate. The purpose of our study is to determine the diagnostic value of complete blood parameters for CAP and to look into their relationship to disease severity and mortality.

methodsA retrospective, the cross-sectional study enrolled children aged 0-18 years who were diagnosed with CAP in the pediatric intensive care unit (PICU) between January 1, 2023 and December 31. The patients included in the study were divided into two groups according to their clinical severity: the moderate group (MG) receiving non-invasive ventilation (NIV) and the severe group (SG) receiving invasive ventilation (IMV) support. In addition to demographic analyses, a comprehensive battery of laboratory tests was conducted on all included patients, and the relationships between mortality and clinical severity were compared. Furthermore, the study also involved the comparison of various biological markers such as mean platelet volume (MPV), C-reactive protein (CRP), albumin, lactate, CRP/MPV, neutrophile/lymphocyte ratio (NLR), lactate/albumin ratio (L/A), and white blood cell (WBC)/MPV values between the two groups, along with an evaluation of their clinical implications.ü

resultsA total of 120 patients were included in the study, the mean age was 44.13 ± 53.03 months, and the mean PICU stay was 11.52 ± 19.75 days. Clinical severity assessment showed that 54 (45%) patients received NIV and 66 (55%) required IMV. Mortality was significantly associated with the type of infectious agent (p = 0.022), respiratory support type (p = 0.019), length of stay (LOS) (p = 0.014), lactate (p = 0.037), and L/A ratio (p = 0.022). ROC analysis revealed that the L/A ratio had a superior predictive value over lactate alone in mortality prediction. Significant differences between MG and SG were observed for LOS (p = 0.006), CRP (p = 0.019), CRP/MPV (p = 0.017), and L/A ratio (p = 0.047). Both CRP/MPV and L/A ratios were significantly higher in the IMV group (p = 0.017, p = 0.047). In the linear regression model, CRP/MPV and L/A ratio were associated with mortality (R²=0.189), with CRP/MPV being 1.1 times more effective in determining respiratory support (p = 0.037, accuracy: 56.7%). CRP/MPV showed a moderate positive correlation with L/A (r = 0.435, p < 0.001), while a weak positive correlation was found between NLR and WBC/MPV (r = 0.264, p = 0.004). No significant correlation was found between LOS and CRP/MPV, NLR, L/A, or WBC/MPV (p > 0.05).

conclusionsMortality was significantly associated with infectious agent type, respiratory support type, LOS, lactate, and L/A ratio. CRP, CRP/MPV, and L/A ratio differed significantly between clinical severity groups. CRP/MPV may be useful in assessing mortality, clinical severity, and respiratory support type. However, L/A ratio was found to be a more valuable predictor of mortality than lactate alone.

Indexed as

Community-Acquired InfectionsPneumoniaAdolescentBiomarkersChildChild, PreschoolC-Reactive ProteinCross-Sectional StudiesFemaleHumansInfantInfant, NewbornIntensive Care Units, PediatricMalePrognosisRetrospective StudiesBiomarkersC-Reactive ProteinBiomarkers in pneumoniaChildrenCommunity-acquired pneumoniaNeutrophilsNeutrophil-to-lymphocyte ratio

Identifiers

PMID40457390
PMCPMC12131600

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.